• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Reporter Benchmarks

  2026-06-04

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) offers dual-mode detection and advanced translation efficiency for mammalian systems. Its Cap1 capping, 5-moUTP modification, and Cy5 labeling support robust mRNA delivery, minimizing innate immune activation and maximizing protein yield.

• Patient-Derived Gastric Cancer Assembloids Enhance Drug Resp

  2026-06-04

  This study introduces a patient-derived gastric cancer assembloid model that integrates tumor organoids with matched stromal cell subpopulations, more closely replicating tumor heterogeneity and microenvironment than conventional organoid cultures. The model enables nuanced drug sensitivity testing and investigation of resistance mechanisms, advancing personalized therapy development.

• Deferasirox Fe3+ Chelate: Strategic Advances in Iron Overloa

  2026-06-03

  This thought-leadership article offers a strategic, mechanistic, and translational perspective on Deferasirox Fe3+ chelate, highlighting its role as a precision tool for iron overload research and chronic anemia management. By integrating clinical findings, workflow guidance, and a visionary outlook, it provides actionable insights for researchers seeking to optimize iron chelation studies and address critical challenges in beta-thalassemia and related disorders.

• Identification of Mubritinib as an Inhibitor of Monkeypox Re

  2026-06-03

  Chiem et al. systematically screened compounds for activity against orthopoxviruses and identified Mubritinib (TAK 165) as an effective in vitro inhibitor of both vaccinia and monkeypox virus replication. These findings expand the utility of Mubritinib beyond cancer biology, highlighting its antiviral potential and providing a foundation for further mechanistic and translational research.

• Cy5 NHS ester(Et): Technical Guide for Protein Labeling Work

  2026-06-02

  Cy5 NHS ester(Et) provides a high-purity, water-soluble route for covalent fluorescent labeling of primary amines in proteins and other biomolecules, supporting detection in immunofluorescence, flow cytometry, and fluorescence microscopy. This reagent is unsuitable for ethanol-based protocols and workflows requiring long-term storage of dye solutions, making it ideal for immediate-use applications where labeling integrity is critical.

• Optimizing Cancer Research with LEE011 Succinate CDK Inhibit

  2026-06-02

  Ribociclib succinate (LEE011 succinate) streamlines cell cycle and proliferation assays with its high selectivity for CDK4/6 and robust solubility profile. This guide details actionable protocols, advanced troubleshooting, and practical cross-references to maximize reliability in HER2-positive cancer research.

• Pam3CSK4 (SKU A9920): Reliable TLR1/2 Agonist for Immune Ass

  2026-06-01

  This article provides scenario-driven, evidence-based guidance for leveraging Pam3CSK4 (SKU A9920) in immune cell activation, inflammation modeling, and cytokine profiling workflows. Drawing on scientific literature and validated best practices, it addresses real-world challenges in reproducibility, assay optimization, and vendor selection, helping life science researchers achieve robust, interpretable results.

• AZ505 and the Translational Frontier of SMYD2 Inhibition

  2026-06-01

  This article delves into the mechanistic and translational landscape of SMYD2 inhibition, spotlighting AZ505 as a potent and selective tool for epigenetic regulation research. Integrating recent evidence from renal fibrosis models and oncology, we outline strategic guidance for translational researchers, distinguishing this discussion from standard product overviews by bridging experimental validation, clinical horizons, and practical protocol considerations.

• Decoding Ubiquitin Signaling: Proteome-wide Interaction Mapp

  2026-05-31

  The reference study introduces UbIA-MS, an affinity enrichment-mass spectrometry workflow that enables comprehensive mapping of protein interactors for distinct ubiquitin chain linkages. Its findings reveal novel linkage-specific binding partners and regulatory mechanisms, providing a resource for unraveling the complexity of ubiquitin-mediated cellular signaling.

• Triamcinolone: Handling and Protocols for Glucocorticoid Res

  2026-05-30

  Triamcinolone is a synthetic glucocorticoid agonist used to precisely modulate glucocorticoid receptor signaling in anti-inflammatory and immunosuppression research. This product is not intended for diagnostic or medical applications, and requires careful attention to solubility and storage to ensure consistent results.

• AO/PI Double Staining Kit: Technical Guide for Cell Viabilit

  2026-05-29

  The AO/PI Double Staining Kit enables rapid and reliable discrimination of viable, apoptotic, and necrotic cells in a single assay using dual fluorescent dyes. It is ideally suited for cell biology experiments where membrane integrity is a key marker of cell fate. This kit is not recommended for use in assays where membrane permeability does not accurately reflect the cell death mechanism under investigation.

• IWP-L6 Porcupine Inhibitor: Precision Tools for Wnt Research

  2026-05-29

  IWP-L6 stands out as a sub-nanomolar Porcupine inhibitor, enabling unparalleled precision in Wnt signaling modulation across developmental, metabolic, and regenerative assays. This guide details applied workflows, protocol enhancements, and troubleshooting strategies for maximizing reproducibility and insight in Wnt pathway research.

• Acetylcysteine in Tumor-Stroma Models: Rethinking Chemoresis

  2026-05-28

  This article explores the mechanistic basis and translational impact of using Acetylcysteine (N-acetyl-L-cysteine) in advanced 3D tumor-stroma co-culture systems. We integrate recent evidence from patient-specific modeling of pancreatic cancer chemoresistance, provide actionable experimental guidance, and position APExBIO Acetylcysteine as a gold-standard reagent for oxidative stress pathway modulation. The discussion extends beyond conventional product pages, offering strategic insights for translational researchers at the interface of redox biology and precision oncology.

• Temozolomide: Small-Molecule Alkylating Agent in Glioma Rese

  2026-05-28

  Temozolomide empowers researchers to precisely induce DNA damage in cancer models, unraveling the complexities of DNA repair and chemotherapy resistance. Discover workflow refinements, troubleshooting solutions, and advanced strategies leveraging Temozolomide's unique properties for high-impact glioma research.

• Levofloxacin in Research: Applied Workflows & Resistance Ins

  2026-05-27

  Levofloxacin, a synthetic fluoroquinolone antibiotic, is uniquely positioned for dissecting bacterial DNA replication and bone metabolism in experimental settings. This article demystifies its dual roles, offers stepwise protocols for both antibacterial and osteoblast studies, and draws on reference data to optimize resistance testing and functional assays.

455 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page